May 2, 2013. Testimony on Juvederm Voluma XC FDA Advisory Committee on General and Plastic Surgery Devices, Caitlin Kennedy, Senior Fellow.
Read More »On Medical Treatments & Products
NCHR Testimony on Tivozanib for Kidney Cancer
May 2, 2013. Dr. Jennifer Yttri testified at the FDA that more information is needed on the safety and benefits of the drug tivozanib before it should be considered for treatment of advanced kidney cancer.
Read More »NCHR Testimony to the FDA Joint Advisory Committee of the FDA on Calcitonin
March 5, 2013. Dr. Jennings testifies to the FDA that the risks of using calcitonin to prevent bone fractures in post-menopausal are greater than the potential benefits.
Read More »NCHR Testimony on Gabapentin
March 4, 2013. Dr. Jennings testifies to the FDA that there is not sufficient evidence to support gabapentin as a safe and effective treatment for hot flashes.
Read More »NCHR Testimony on Paroxetine (Brisdelle)
March 4, 2013. Dr. Mary Carol Jennings testifies to the FDA on the risks of using Paroxetine (Brisdelle) to treat hot flashes.
Read More »